BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9537419)

  • 1. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
    Hyde RK; Griep AE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
    Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
    EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An E2F dominant negative mutant blocks E1A induced cell cycle progression.
    Dobrowolski SF; Stacey DW; Harter ML; Stine JT; Hiebert SW
    Oncogene; 1994 Sep; 9(9):2605-12. PubMed ID: 8058324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional inhibition by the retinoblastoma protein.
    Fattaey A; Helin K; Harlow E
    Philos Trans R Soc Lond B Biol Sci; 1993 Jun; 340(1293):333-6. PubMed ID: 8103936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
    Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
    Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC; Hickman ES; Lazzerini Denchi E; Caprara G; Colli E; Cecconi F; Müller H; Helin K
    Nat Cell Biol; 2001 Jun; 3(6):552-8. PubMed ID: 11389439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A; Marcellus RC; Corbeil HB; Branton PE
    Oncogene; 1999 Mar; 18(12):2091-100. PubMed ID: 10321733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
    Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E2F1-3 transcription factors are essential for cellular proliferation.
    Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
    Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.